The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients
Crossref DOI link: https://doi.org/10.1186/1475-2840-13-92
Published Online: 2014-05-14
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Poncina, Nicol
Albiero, Mattia
Menegazzo, Lisa
Cappellari, Roberta
Avogaro, Angelo
Fadini, Gian Paolo
Article History
Received: 18 February 2014
Accepted: 9 May 2014
First Online: 14 May 2014